Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 164 for Prostate cancer

Edit search filters
  1. A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft

    Rochester, MN

  2. A Study to Detect Prostate Cancer Extraprostatic Extension with Slip Interface Imaging Determined Tumor Slip Length

    Rochester, MN

  3. A Study to Assess Imaging Tools for Patients Who Have Prostate Removal Surgery

    Scottsdale/Phoenix, AZ

  4. A Study to Compare Outcomes of Patients Who Underwent Open and Robotic Prostatectomy for Prostate Cancer

    Rochester, MN

  5. A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

    Scottsdale/Phoenix, AZ

  6. Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer

    Rochester, MN

  7. Tele-Medicine in an Advanced Prostate Cancer Clinic

    Rochester, MN

  8. DNA Methylation in Adenocarcinoma of the Prostate: Tissue Validation of Biomarkers and Pilot Testing in Blood

    Rochester, MN

  9. Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  10. Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

    Rochester, MN

.

Mayo Clinic Footer